Listed

Editas Medicine, Inc.

EDITNasdaqCIK 1650664HealthcareFiscal year ends Dec 31

Reports and events: 192 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Editas Medicine, Inc., Reports and events
FiledFormWhat it isAccession number
2017-12-2216:02 ET8-K5.02 Departure or appointment of officers or directors0001558370-17-009439
2017-12-1216:01 ET8-K2.03 New direct financial obligation0001558370-17-009299
2017-12-0716:23 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-072309
2017-11-0817:39 ET10-QQuarterly reportPeriod 2017-09-300001558370-17-008429
2017-11-0716:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-17-008386
2017-09-2216:01 ET8-K3.02 Unregistered sale of equity0001558370-17-007143
2017-09-1816:26 ETSC 13D/AOwnership report, active investor, amended0001193125-17-287347
2017-08-0916:13 ET10-QQuarterly reportPeriod 2017-06-300001558370-17-006422
2017-08-0916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-17-006420
2017-06-1916:05 ET8-K5.07 Shareholder vote results0001558370-17-004878
2017-05-3116:31 ET8-K5.02 Departure or appointment of officers or directors0001558370-17-004610
2017-05-3017:19 ETSC 13D/AOwnership report, active investor, amended0001193125-17-187591
2017-05-1516:48 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-17-004359
2017-05-1516:20 ET10-QQuarterly reportPeriod 2017-03-310001558370-17-004338
2017-04-2616:07 ETDEF 14AProxy statementPeriod 2017-06-150001047469-17-002939
2017-03-3116:07 ET8-K2.03 New direct financial obligation0001558370-17-002366
2017-03-1716:49 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-017627
2017-03-1508:45 ET8-K1.01 Entry into a material agreement0001558370-17-001804
2017-03-0716:09 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001558370-17-001417
2017-03-0716:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-17-001412
2017-03-0316:52 ET10-KAnnual reportPeriod 2016-12-310001558370-17-001340
2017-03-0309:05 ET8-K5.02 Departure or appointment of officers or directors0001558370-17-001314
2017-01-2316:05 ET8-K9.01 Financial statements and exhibits0001558370-17-000174
2016-12-2108:00 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001558370-16-010591
2016-11-0916:08 ET10-QQuarterly reportPeriod 2016-09-300001558370-16-009820
2016-11-0716:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-16-009504
2016-09-1916:51 ETSC 13D/AOwnership report, active investor, amended0001193125-16-713550
2016-09-0216:10 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001558370-16-008170
2016-08-1007:31 ET10-QQuarterly reportPeriod 2016-06-300001558370-16-007838
2016-08-0916:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-16-007791
2016-08-0816:30 ET8-K1.01 Entry into a material agreement0001558370-16-007659
2016-07-2916:20 ET8-K5.02 Departure or appointment of officers or directors0001558370-16-006975
2016-05-1616:41 ETSC 13DOwnership report, active investor0001193125-16-591961
2016-05-1607:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-16-006005
2016-05-1316:08 ET10-QQuarterly reportPeriod 2016-03-310001558370-16-005983
2016-04-1116:30 ET8-K5.02 Departure or appointment of officers or directors0001558370-16-004590
2016-03-3016:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-16-004476
2016-03-3018:45 ET10-KAnnual reportPeriod 2015-12-310001558370-16-004455
2016-02-1916:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-16-098504
2016-02-0816:38 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001047469-16-010055
2016-01-2506:07 ETS-1/ARegistration statement, amended0001047469-16-009819
2016-01-0417:07 ETS-1Registration statement0001047469-16-009534

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:42 ET. Listed shows no prices and gives no investment advice.